← Back to Search

Cannabinol for Knee Replacement Surgery (COPE Trial)

Phase 2 & 3
Waitlist Available
Led By Amit Atrey, MD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is able to provide informed consent to participation in the study
18 years of age and older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks after total knee replacement
Awards & highlights

COPE Trial Summary

This study is evaluating whether medical cannabis can reduce the amount of opiates needed after knee replacement surgery.

COPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

COPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks after total knee replacement
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks after total knee replacement for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid consumption
Secondary outcome measures
Health status and quality of life
Narcotics
Oxford knee score
+3 more

COPE Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Medical CannabisExperimental Treatment1 Intervention
Drug: Cannabidiol
Group II: PlaceboPlacebo Group1 Intervention
Placebo comparator
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabinol
Not yet FDA approved

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
533 Previous Clinical Trials
446,243 Total Patients Enrolled
Amit Atrey, MDPrincipal InvestigatorUnity Health Toronto
3 Previous Clinical Trials
582 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~46 spots leftby Mar 2025